Corvus Pharmaceuticals (CRVS) Q2 2023 Earnings

Aug 8Confirmed
Aug 2022
Nov 2022
Q1 2023
Q2 2023
-0.32
-0.26
-0.2
-0.14

Details

Expected EPS
-0.14
Actual EPS
-0.14
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Corvus Pharmaceuticals⁩ (⁦CRVS⁩) has reported earnings of ⁦-0.14⁩ per share for ⁦Q2 2023⁩.

0 Comments

Share your thoughts